Cyclerion Therapeutics, Inc.

10-Q Quarter ended 2026-03-31 May 12, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Entered a material agreement; Change in control; Director or officer change; Regulation FD disclosure Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Regulation FD disclosure Feb 17, 2026 8-K Entered a material agreement; Regulation FD disclosure Jan 6, 2026 8-K Other events Dec 1, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 10-K/A Fiscal year ended 2024-12-31 Nov 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Sep 23, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Shareholder vote results Jun 18, 2025 8-K Entered a material agreement May 7, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Regulation FD disclosure Aug 7, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Other events Apr 18, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Director or officer change; Regulation FD disclosure Dec 4, 2023 8-K Director or officer change; Regulation FD disclosure Dec 1, 2023 8-K Director or officer change Nov 24, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Director or officer change Oct 23, 2023 10-Q Quarter ended 2023-06-30 Jul 28, 2023 8-K Shareholder vote results Jul 19, 2023 8-K Other events Jul 12, 2023 8-K Director or officer change Jun 27, 2023 8-K Other events Jun 1, 2023 8-K Unregistered sale of equity; Amended charter or bylaws May 25, 2023 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure; Other events May 15, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure; Other events May 12, 2023 8-K Regulation FD disclosure Apr 3, 2023 10-K Fiscal year ended 2022-12-31 Mar 22, 2023